PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28580424-2	2017	We report the unbinding dynamics of the anticancer drug dasatinib from c-Src kinase in full atomistic resolution using enhanced sampling molecular dynamics simulations.	Dasatinib	56-65	C-terminal Src kinase	Homo sapiens	71-83	
34472425-0	2021	Complete reconstruction of dasatinib unbinding pathway from c-Src kinase by supervised molecular dynamics simulation method; assessing efficiency and trustworthiness of the method.	Dasatinib	27-36	C-terminal Src kinase	Homo sapiens	60-72	
34472425-4	2021	In this work, we utilized this strategy to reconstruct the unbinding pathway of the anticancer drug dasatinib from its target protein, the c-Src kinase.	Dasatinib	100-109	C-terminal Src kinase	Homo sapiens	139-151	
32525544-7	2020	Here, we have described a dynamical binding"s process of an anticancer drug, the dasatinib, to the c-Src kinase in full atomistic details for the first time, without applying any biasing force or potential which may lead the drug to artificial interactions with the protein.	Dasatinib	81-90	C-terminal Src kinase	Homo sapiens	99-111